Home Blog

Amazon Deal: Baseus 100W 20,000mAh Power Bank for $59.99


Amazon: Baseus 100W 20,000mAh Power Bank for $59.99

This article contains Amazon affiliate links.

Amazon has the Baseus Blade 100W 20,000mAh Portable Power Bank on sale for $59.99, down from the listed price of $89.99. That’s a savings of $30, or 33% off.

This slim portable charger is designed for laptops, tablets, smartphones and other devices. It delivers up to 100W USB-C fast charging, with Baseus claiming it can charge a MacBook Pro to 50% in about 30 minutes.

The power bank features two USB-C ports and two USB-A ports, allowing you to charge up to four devices at once. It also has a built-in display showing battery and charging information, plus a flat design that makes it easy to slip into a laptop bag. The 20,000mAh capacity makes it useful for travel, and a USB-C cable is included.

BUY NOW

Guru’s Wrap-up

A solid discount on a powerful portable charger that can handle more than just phones. The 100W output, four charging ports and slim design make this a useful option for travelers.

 

Disclaimer: As an Amazon Associate I earn from qualifying purchases made through this article. Using links on the site for Amazon purchases is the best way you can support the site as you normally can’t earn cash back for these purchases. But, you should still check shopping portals such as Rakuten, TopCashback, RebatesMe, ShopBack and others for possible cashback. Your support is always greatly appreciated!

Strategy buys $21 million worth of Bitcoin as corporate crypto buying shows signs of revival



Bitcoin buying is back. Corporate crypto heavyweight Strategy announced Monday that it bought over $21 million worth of Bitcoin last week, bringing its total holdings to roughly $70 billion. The company, led by flamboyant billionaire Michael Saylor, funded the purchase by selling more than 125,000 shares of its common stock and using $500,000 in cash. It also spent roughly $192 million to repurchase nearly 2 million shares of STRC, a type of preferred stock that makes regular payments to investors.

The latest purchase extends Strategy’s return to Bitcoin buying, marking its fifth purchase since August.

Bitcoin broke out of a prolonged trading lull in mid-August, climbing to around $77,000 for the first time since May. It has largely held above that level since and was trading at $82,600 Monday morning. The rebound followed a steep downturn that pushed Bitcoin from a high of $126,000 last October to a low of $58,000 in June. Amid the slump, Strategy—which holds roughly 4% of Bitcoin’s circulating supply—sold portions of its stockpile on four occasions. As Bitcoin’s price rebounded, Strategy stopped selling and returned to stockpiling.

Strategy isn’t the only big player wading back into Bitcoin. Other companies have recently added crypto to their balance sheets, breathing life back into corporate crypto buying. 

Earlier this month, Strive, the asset manager cofounded by billionaire Vivek Ramaswamy, announced a $169 million purchase of 2,000 Bitcoin, bringing its stockpile to roughly $2.4 billion. Robinhood, the crypto trading platform led by CEO Vlad Tenev, also joined the ranks of corporate Bitcoin buyers and recently disclosed a $25 million investment for its own balance sheet. Metaplanet, the Japanese investment firm and world’s second-largest publicly traded Bitcoin treasury company, announced this month that it sold 10,000 Bitcoin and bought 11,000 in the third quarter to demonstrate to credit markets that it could convert its holdings into cash when needed.

But companies aren’t just stockpiling Bitcoin. Bitmine, a Bitcoin miner turned into an Ethereum treasury company, announced this month that it had added roughly $41 million worth of the cryptocurrency to its treasury. The purchase brought its holdings to about 6 million tokens—nearly 5% of Ether’s total supply.

The renewed buying comes as Bitcoin’s recovery fuels hopes of further gains. The cryptocurrency has held up despite recent interest rate hikes in the United States and renewed tensions in the Middle East.

Fortune previously reported that analysts expect Bitcoin to recover further by year-end, with one strategist predicting a summer bottom followed by a rebound toward $100,000.

Fortune Daily breaks the traditional barrier between audience and newsroom. The show transforms Fortune’s trusted reporting into actionable, conversational, and entertaining insights for an emerging class of business leaders. Watch here.

Election betting: 60% of Americans oppose prediction-market wagers



Americans can turn their predictions about who will control Congress into a bet, but most don’t think they should. With the midterms approaching, 60% of U.S. adults oppose using prediction markets to wager on election results, while 13% support it and 24% are unsure, according to a Reuters/Ipsos poll provided to Fortune.

They’ll see the odds anyway. CBS News said Sept. 30 it would add real-time prices from Kalshi to its midterm coverage, alongside its own polling. Kalshi has similar deals with CNN and CNBC, and it licenses vote counts and race calls from the Associated Press. CBS News and CNN now share an owner: Skydance, which completed its purchase of CNN’s parent, Warner Bros. Discovery, on Oct. 6.

Those prices can rest on a small number of traders. On Polymarket’s global platform, the top 1% of wallets account for 68% of trading volume on 2026 congressional markets, and 80% of those markets have fewer than 100 wallets trading, according to an August analysis by the Anti-Corruption Data Collective, a nonprofit research and advocacy group.

The opposition crosses party lines, with 69% of Democrats and 61% of Republicans opposing election betting. Three-quarters of Americans consider prediction-market wagering a form of gambling. Only 7% of respondents said they had used a prediction market to bet money.

“Most view prediction markets as a form of gambling, and it’s clear that they do not see elections or government decision-making as appropriate subjects for it,” Alec Tyson, a senior vice president and lead pollster at Ipsos U.S. Public Affairs, told Fortune.

Ipsos surveyed 4,506 U.S. adults from Sept. 30 through Oct. 5. The margin of sampling error is plus or minus 1.5 percentage points.

But monthly global trading volume and public approval measure different things. Sports offer what elections struggle to match: frequent events and fast-changing odds that give people more reasons to trade, said Dustin Gouker, a gambling industry analyst and author of the prediction market newsletter The Event Horizon. 

A poll or campaign development can move an election market. A sports game can move odds and produce those shifts within minutes as teams score and leads change. 

“I don’t think it’s necessarily that election trading isn’t popular,” Gouker told Fortune. “It’s more that it doesn’t feature some of the things that we see in these markets that are seeing more volume.”

Combined monthly trading volume on Kalshi and Polymarket more than doubled, from about $26 billion in May to $53 billion in July, according to a September Pew Research Center analysis. Sports drove most of that increase. Users buy and sell contracts on whether an event will happen; winning contracts pay $1 and losing ones pay nothing.

Those totals cover all trading and count contracts at their potential $1 payout rather than their purchase price. They don’t represent company revenue or the cash traders spent.

Kalshi challenges the findings

Kalshi called the poll biased, challenging how it described prediction markets and asked about wagering on government events. 

“It’s not hard to bias a poll and this poll is biased,” a Kalshi spokesperson said in a statement to Fortune. “Ask leading questions about whether people support ‘betting on war,’ and you’ll get the answers this poll arrived at. Kalshi doesn’t even offer war markets.” 

The questionnaire didn’t use the word “war.” It described prediction markets as allowing people to “wager money on the outcome of real-world events.” It then asked separately about elections, military actions, government policy decisions, and sports and did not measure familiarity. A March Ipsos poll for the American Institute for Boys and Men found just 21% of Americans were very or somewhat familiar with prediction markets.

“We welcome research on our industry, but a clearer picture would come from research that measures familiarity, uses neutral wording, and reports all responses,” Kalshi said.

Ipsos did not respond to Kalshi’s criticism by publication time.

Traders sued Kalshi earlier this year in March over its handling of a market on whether Iran’s supreme leader, Ali Khamenei, would leave office. The dispute followed his killing in U.S.-Israeli strikes. Kalshi told Reuters at the time that the rules excluded death-related outcomes and that it had reimbursed trading fees and net losses.

Election odds aren’t election results

Polymarket argues that its audience extends beyond bettors. More than 90% of visits are to view markets rather than trade, a spokesperson told Fortune. “Prediction markets are a way to get unbiased, accurate information about the events that impact our lives,” the spokesperson said.

Gouker said election markets attract viewers by distilling polls and news into a probability, but turning those visitors into traders is a separate business challenge. He expects election trading to pick up as the midterms approach, though doubts it will get to the level of sports betting. He also expects the 2028 presidential election to draw more trading than this year’s midterms. 

He cautioned against treating high odds as a call of the race. Gouker pointed to Abdul El-Sayed’s Michigan primary, saying markets showed him as an overwhelming favorite around the close of voting before incoming results suggested a closer contest. El-Sayed led by just under one percentage point when the Associated Press called the race.

A candidate with a 70% chance of winning still has a 30% chance of losing. To judge a market’s accuracy, Gouker said, look at whether outcomes occur as often as the odds suggest: “When a market says something should happen, it happens roughly the amount of times we would expect it to.”

He added, “You have to look at them as probabilities and not as these crystal balls.”

5 Reasons Why You Shouldn't Study Business Management Degree



Why you shouldn’t study business management or any business degree and cons of business management degrees and cons of being a business major.

Should I study business? Should I major in business? Should I do a business management degree? If these are questions you ask yourself, please watch this whole video and you will understand the cons of studying business and the reasons to not major in business. Of course, I will be also listing out the pros of business degree and why you should study business, but that’s for another video hehe.

📹RELATED VIDEOS:
Studying in the UK:
How I graduated with a first in uni:
MiM vs MBA:
Working from home morning routine:
Which MiM is the best: LBS, LSE, Imperial, UCL:
London Business School Q&A:

⚙️ MY EQUIPMENT:
Camera
Tripod

🌸 INSTAGRAM:
🎵TIKTOK:

👩🏻‍💼WHO AM I: Heyo! I’m a Masters in Management graduate from London Business School who is currently working as a graduate consultant. I am also a former recruiter for an investment bank, and have worked in marketing throughout uni (wow this sounds like a CV). I make videos about the university experience, kickstarting your corporate career, life in London, and other lifestyle videos! If this sounds interesting to you, feel free to subscribe and start your success journey with me 😊❤️

🎶 MUSIC BY: LAKEY INSPIRED @

source

Where are all the Portfolio Managers’ Large Language Models


We would argue that the greatest barriers to AI adoption are not technological. They are the same human traits that we’ve seen before. Let’s take a deeper dive into a few of the most significant:

1.  The “AI champion” may be the wrong person

Many firms put AI adoption in the hands of technology, data science, operations, or innovation teams. These are professional and well-meaning teams but lack the skills necessary to train PMs on how to use AI effectively.

The message is too often, “Here is a tool. Best of luck in using it in your process.” A more effective approach sounds like, “Here is how this improves the quality of our investment judgment.”

2.  Time scarcity makes experimentation feel expensive

PMs and analysts are overloaded. Earnings seasons, portfolio reviews, client meetings, market events, risk reviews, and internal meetings consume the calendar. LLM adoption is an investment that requires a temporary productivity dip: learning prompts, redesigning workflows, testing use cases, comparing outputs, and building team norms.

The long-term payoff may be substantial, but the short-term cost is real. Busy professionals often reject new tools not because they doubt their long-term efficacy, but because they cannot tolerate the short-term transition cost.

3.  Lack of psychological safety, including around learning in public

LLM adoption requires people to be beginners and show vulnerability. Senior PMs especially dislike feeling this way. They may avoid workshops, demos, or peer learning because they don’t want to tarnish their image of being the wise leader.

This is an EQ issue, not a technical one. Firms that adopt faster will already have psychologically safe environments, encourage experimentation, expect and celebrate failure, and be comfortable with peer learning.

4.  The rewards system doesn’t recognize process improvement

PMs are usually paid for performance, asset retention, client confidence, and commercial outcomes. Analysts are rewarded for good ideas, differentiated work, responsiveness, and credibility with PMs.

Few firms explicitly reward better research workflows, higher-quality debate, more systematic decision reviews, better information sharing, or improved knowledge capture. So LLM adoption becomes an unpaid extra effort. The firm may say AI matters, but the incentive system says: “Keep doing what already gets you paid.”

5.  “Responsible use of AI” often feels risky rather than enabling

Fear dominates many AI conversations: privacy, hallucination, cyber risk, compliance, regulation, model risk. These are all valid concerns in our heavily regulated industry. If the organizational narrative is primarily defensive, however, PMs will conclude that AI use is dangerous, not encouraged.

This directly maps to the behavioral finance concept of the penalties for sins of commission being higher than sins of omission. This occurs when an organization creates an environment where an actual mistake is penalized but a missed opportunity is not. Good investment teams understand this and take steps to ensure it doesn’t occur. One way of doing so is when PMs ensure they are taking sufficient risk in their portfolios to deliver the promised alpha. This same concept should apply to AI – make sure you are taking some risk and recognize employees who try new ways of using the models, even if they fail.

6.  Probably the greatest hurdle of all – process engineering

Process engineering is the discipline of deliberately designing, analyzing, improving, and controlling an investment process so that a desired outcome is produced more reliably, efficiently, and consistently. I would argue that many investment firms do not have an AI problem. They have a process-engineering problem that AI is revealing. Many investment managers don’t naturally think in terms of process-engineering, making it harder for them to see how AI can truly advance their investment process.

Ottawa reviews foreign homebuyer ban as 2027 expiry approaches




Finance Minister François-Philippe Champagne says the federal government is mulling its options ahead of the expiry of Canada’s foreign homebuyers ban at the end of the year.

(Update: CITGO Added) Walmart+ Members Get Gas Discount $.10/gallon At Exxon & Walmart Gas Stations


Update 10/11/26: CITGO has been added as an option. 

(Update 8/16/23: They are offering a temporary doubling with 20 cents back from August 15 through September 15.)

Walmart+ just added a new benefit for members to get 10 cents off per gallon of gas at Exxon, Mobil, Walmart, and Murphy gas stations. Previously the discount was only for Walmart/Murphy stations, and only 5 cents. Walmart+ also provides access to member prices at Sam’s Club fuel centers.

Press Release | Walmart link

Nice how they expanded the partnership with Exxon. A lot of us have Walmart+ free with the AmEx Platinum card. If you use Exxon or Walmart gas this can be a little gas savings. The process of getting the savings through your Walmart+ account within the Walmart app looks like a bit of a pain, but I guess it could be worth it for larger tanks, especially.

Stifel reiterates Hold on Kontoor Brands stock, $80 target maintained




Stifel reiterates Hold on Kontoor Brands stock, $80 target maintained

This Drug Combination for Eli Lilly Generated Significantly More Weight Loss Than Just Zepbound, but Discontinuation Rates Were Also Far Higher. Here’s What This Could Mean for the Stock


Although Eli Lilly (LLY +0.83%) is a leader in the GLP-1 space, the drugmaker continues to develop new and potentially better treatments for people to lose weight. Not everyone has success with GLP-1 drugs or can effectively tolerate them.

Recently, the company released trial results that suggested a combination treatment involving tirzepatide (the active ingredient in Zepbound), along with another drug, resulted in even greater weight loss. But there was a catch — discontinuation rates were higher. What does this ultimately mean for investors, and is the healthcare stock worth buying on this news?

Image source: Getty Images.

Trial participants achieved weight loss of up to 23.3%

After a period of just 48 weeks, patients who took tirzepatide along with eloralintide, which is an experimental drug that targets amylin, a natural hormone, but not GLP-1, achieved considerably more weight loss than just taking either drug alone. Patients who took a treatment that involved both drugs lost up to 23.3% of their weight versus just 14.8% with tirzepatide. Meanwhile, people who only took eloralintide lost up to 12.3%.

The one concern with the trial, however, was that a large number of people who took the combination treatment stopped it due to side effects. The discontinuation rate was as high as 27%, potentially suggesting that it wasn’t well-tolerated among patients. But dosing can have a big impact on that, and the company’s President of Lilly Cardiometabolic Health, Ken Custer, says high discontinuation rates weren’t uncommon for tirzepatide either when it was in a mid-stage trial several years ago.

Eli Lilly Stock Quote

Today’s Change

(0.83%) $9.67

Current Price

$1,179.27

Eli Lilly’s growth potential remains promising

Overall, these recent trial results were a net positive for Eli Lilly, as they suggest the company is on a promising path as it continues to look for ways to build up its lead in the anti-obesity market. Rather than just sitting back on its approvals thus far, the company has demonstrated a strong willingness and eagerness to stay ahead of the competition. It’s already dominating the anti-obesity market today, and yet, it’s still looking for the next best solution for patients. That’s a sign of a great growth-oriented business.

The one potential obstacle for the stock today is its valuation. Eli Lilly has a market cap of more than $1 trillion, and it trades at close to 40 times its trailing earnings. Its valuation is steep. I do, however, believe it can still rise higher given its dominance and success. But investors may want to temper their expectations. Eli Lilly’s stock is up around 10% this year, and while it may be an excellent long-term investment, its gains may be modest in the near term.

How to Invest in Your 30s | Complete Step-by-Step Guide



Get Spam-Free Insurance Advice by Ditto👇

Navigating your financial strategy in your 30s is all about leveraging your growing earning power while balancing bigger life milestones with long-term security.

This video breaks down a structured and practical investment blueprint tailored specifically for this decade, focusing on smart asset allocation, balancing high-growth opportunities with risk management, and accelerating your path to financial independence.

If you found this video helpful, please like, subscribe to the channel, and share your thoughts in the comments below.
_________________________________________________________________________________

00:00 – Introduction
00:50 – Avoid Loans For Depreciating Assets
02:47 – Insure Everything You Cannot Lose
04:46 – Secure Your Retirement Through NPS
05:57 – DIY vs Assisted Investing
08:47 – Fee-only advisors vs Commission-backed distributors
11:46 – Free Financial Check-up Guide
12:09 – Conclusion
_____________________________________________________________________

➡️ Get 30 Stocks For Long Term:

➡️Get Your Financial Check-Up Done:

➡️ The Modern Stock Screener:

➡️ Checkout Finology Deepscan:

➡️ Join my WhatsApp channel:

➡️ Open Zerodha Demat Account for FREE –

➡️ Buy Investonomy:

➡️ 5 Investing Books from Beginner to Advanced:
____________________________________________________________________________________

➡️ For disclosures and regulatory information, visit:
____________________________________________________________________________________

Get in Touch:
⏩ Email Us – support@finology.in
🌐 Website –
📞 For queries, contact – 022-489-66660

source